The Playbook provides a practical, user-friendly guide to navigating the complexities of data sharing in IMI/IHI collaborative health research projects, outlining key concepts, roles, decision points, common challenges, and strategies to address legal, technical, and organisational obstacles. It encourages early planning, stakeholder engagement, and adoption of standardised best practices to accelerate data sharing and improve research efficiency across multi-partner consortia
View this resource Bookmark this resourceIHI
The Innovative Health Initiative Joint Undertaking (IHI JU) is a partnership between the European Union
and industry associations representing the sectors involved in healthcare, namely COCIR (medical
imaging, radiotherapy, health ICT and electromedical industries); EFPIA, including Vaccines Europe
(pharmaceutical industry and vaccine industry); EuropaBio (biotechnology industry); and MedTech
Europe (medical technology industry).
IHI JU aims to pioneer a new, more integrated approach to health research and builds on the experience
gained from the Innovative Medicine Initiative 2 Joint Undertaking (IMI2 JU).
IHI JU aims to translate health research and innovation into real benefits for patients and society, and
ensure that Europe remains at the cutting edge of interdisciplinary, sustainable, patient-centric health
research. Health research and care increasingly involve diverse sectors. By supporting projects that bring
these sectors together, IHI JU will pave the way for a more integrated approach to health care, covering
prevention, diagnosis, treatment, and disease management.
As current health challenges and threats are global, IHI JU should be open to participation by
international academic, industrial and regulatory actors, in order to benefit from wider access to data and
expertise, to respond to emerging health threats and to achieve the necessary societal impact, in
particular improved health outcomes for Union citizens
The Innovative Health Initiative Joint Undertaking (IHI JU) is a partnership between the European Union
and industry associations representing the sectors involved in healthcare, namely COCIR (medical
imaging, radiotherapy, health ICT and electromedical industries); EFPIA, including Vaccines Europe
(pharmaceutical industry and vaccine industry); EuropaBio (biotechnology industry); and MedTech
Europe (medical technology industry).
IHI JU aims to pioneer a new, more integrated approach to health research and builds on the experience
gained from the Innovative Medicine Initiative 2 Joint Undertaking (IMI2 JU).
IHI JU aims to translate health research and innovation into real benefits for patients and society, and
ensure that Europe remains at the cutting edge of interdisciplinary, sustainable, patient-centric health
research. Health research and care increasingly involve diverse sectors. By supporting projects that bring
these sectors together, IHI JU will pave the way for a more integrated approach to health care, covering
prevention, diagnosis, treatment, and disease management.
As current health challenges and threats are global, IHI JU should be open to participation by
international academic, industrial and regulatory actors, in order to benefit from wider access to data and
expertise, to respond to emerging health threats and to achieve the necessary societal impact, in
particular improved health outcomes for Union citizens.
The Innovative Health Initiative Joint Undertaking (IHI JU) is a partnership between the European Union
and industry associations representing the sectors involved in healthcare, namely COCIR (medical
imaging, radiotherapy, health ICT and electromedical industries); EFPIA, including Vaccines Europe
(pharmaceutical industry and vaccine industry); EuropaBio (biotechnology industry); and MedTech
Europe (medical technology industry).
IHI JU aims to pioneer a new, more integrated approach to health research and builds on the experience
gained from the Innovative Medicine Initiative 2 Joint Undertaking (IMI2 JU).
IHI JU aims to translate health research and innovation into real benefits for patients and society, and
ensure that Europe remains at the cutting edge of interdisciplinary, sustainable, patient-centric health
research. Health research and care increasingly involve diverse sectors. By supporting projects that bring
these sectors together, IHI JU will pave the way for a more integrated approach to health care, covering
prevention, diagnosis, treatment, and disease management.
As current health challenges and threats are global, IHI JU should be open to participation by
international academic, industrial and regulatory actors, in order to benefit from wider access to data and
expertise, to respond to emerging health threats and to achieve the necessary societal impact, in
particular improved health outcomes for Union citizens.
